Search for Clinical Trial Results
Marginal Zone Lymphoma - 26 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma Condition: Splenic Marginal Zone Lymphoma Date: 2016-10-23 |
Completed |
Study Name: Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma Condition: MALT Lymphoma Date: 2005-09-13 Interventions: Other: Omeprazole, Amoxicillin, Clarithromycin Omeprazole20 mg,Clarithromycin500 mg b.i.d.,Day 1-14 plus |
Active, not recruiting |
Study Name: Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma Condition: MALT Lymphoma Date: 2013-03-06 Interventions:
|
Completed |
Study Name: Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL) Condition: Marginal Zone B-cell Lymphoma Date: 2010-07-15 Interventions: Drug: Everolimus Everolimus (tablets, 5 mg) is given orally at the dose of 10 mg/day from day 1 to day 2 |
Recruiting |
Study Name: Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma Condition: Mucosa-Associated Lymphoid Tissue Lymphoma Date: 2016-12-01 |
Terminated |
Study Name: Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma Condition:
|
Terminated |
Study Name: 131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma Condition: Relapsed or Refractory Marginal Zone B-cell Lymphoma Date: 2012-09-04 Interventions: Drug: 131I-rituximab |
Completed |
Study Name: Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori Condition: Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive Date: 2010-12-20 Interventions: Drug: Rabeprazole Sodium The following 3 drugs are taken o |
Completed |
Study Name: Velcade in MALT Lymphoma Patients Condition: MALT Lymphoma Date: 2006-09-07 Interventions: Drug: Bortezomib (Velcade) |
Completed |
Study Name: Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome Condition: Gastric MALT Lymphoma Date: 2006-05-17 Interventions: Drug: Omeprazole, Amoxicillin, Clarithromycin |